Current Developments of Clinical Sequencing and the Clinical Utility of Polygenic Risk Scores in Inflammatory Diseases
In this mini-review, we highlight selected research by the Deutsche Forschungsgemeinschaft (DFG) Cluster of Excellence “Precision Medicine in Chronic Inflammation” focusing on clinical sequencing and the clinical utility of polygenic risk scores as well as its implication on precision medicine in th...
Main Authors: | Matthias Hübenthal, Britt-Sabina Löscher, Jeanette Erdmann, Andre Franke, Damian Gola, Inke R. König, Hila Emmert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.577677/full |
Similar Items
-
Polygenic Score Models for Alzheimer’s Disease: From Research to Clinical Applications
by: Xiaopu Zhou, et al.
Published: (2021-03-01) -
Polygenic and miltufactorial disorders
by: Pajović Snežana B.
Published: (2007-01-01) -
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
by: Dimitrios Vlachakis, et al.
Published: (2021-06-01) -
Statistical genetics and polygenic risk score for precision medicine
by: Takahiro Konuma, et al.
Published: (2021-06-01) -
Empirical Bayes Estimation of Semi-parametric Hierarchical Mixture Models for Unbiased Characterization of Polygenic Disease Architectures
by: Jo Nishino, et al.
Published: (2018-04-01)